Fig. 4From: Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutationsDynamic monitoring in nine EGFR / ALK co-mutated patientsBack to article page